KHORANAVTE Risk Assessment in Cancer Patients
Clinical & Lab Factors
Guidelines & Evidence
Verified
Last Review: 2026
Last Comprehensive Review: 2026
Clinical Context
We think this might be relevant to the clinical guidance for Khorana Score (VTE Risk in Cancer).
Clinical Context
We think this might be relevant to the clinical guidance for Khorana Score (VTE Risk in Cancer).
Clinical Context
We think this might be relevant to the clinical guidance for Khorana Score (VTE Risk in Cancer).
KHORANAVTE Risk Assessment in Cancer Patients
Risk Profile
Prophylaxis Strategy
Score 0. Low risk for VTE. Routine prophylactic anticoagulation is generally not indicated.
Verified
Last Review: 2026
Last Comprehensive Review: 2026
